Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer

Cuproptosis Regulates Microenvironment and Affects Prognosis in Prostate Cancer

(2023) Chao Li et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell

(2023) Wei Zhou et al.   MOLECULAR & CELLULAR PROTEOMICS

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance

(2022) Chen Zhang et al.   Molecular Cancer

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer

(2022) Zaoqu Liu et al.   Nature Communications

Programmed Cell Death Tunes Tumor Immunity

(2022) Jing Liu et al.   Frontiers in Immunology

RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer

(2022) Biao Xie et al.   Frontiers in Oncology

Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity

(2022) Lu Wang et al.   ADVANCED MATERIALS

Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma

(2022) Hao Zhang et al.   BRIEFINGS IN BIOINFORMATICS

NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022

(2022) Deborah K. Armstrong et al.   Journal of the National Comprehensive Cancer Network

Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery

(2022) Yutian Zou et al.   International Journal of Surgery

Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma

(2022) Juan Zhang et al.   Frontiers in Oncology

Autophagy in major human diseases

(2021) Daniel J Klionsky et al.   EMBO JOURNAL

Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model

(2021) Leilei Liang et al.   Frontiers in Oncology

Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma

(2021) Wanli Lin et al.   Cell Death Discovery

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer

(2021) Zaoqu Liu et al.   EBioMedicine

Large-scale public data reuse to model immunotherapy response and resistance

(2020) Jingxin Fu et al.   Genome Medicine

Targeting tumor microenvironment in ovarian cancer: Premise and promise

(2020) Yuting Jiang et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

TIMER2.0 for analysis of tumor-infiltrating immune cells

(2020) Taiwen Li et al.   NUCLEIC ACIDS RESEARCH

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

(2020) Yuanyuan Zhang et al.   Cellular & Molecular Immunology

An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma

(2020) Yifei Dai et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma

(2020) Yunfan Sun et al.   CELL

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies

(2020) Aleksandra Klemba et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Delivery technologies for cancer immunotherapy

(2019) Rachel S. Riley et al.   NATURE REVIEWS DRUG DISCOVERY

The molecular machinery of regulated cell death

(2019) Daolin Tang et al.   CELL RESEARCH

Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer

(2019) Li Liu et al.   CLINICAL CANCER RESEARCH

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

(2018) Lorenzo Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

How the Warburg effect supports aggressiveness and drug resistance of cancer cells?

(2018) Philippe Icard et al.   DRUG RESISTANCE UPDATES

BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors

(2018) Garrett W. Rhyasen et al.   PLoS One

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

(2015) Ende Zhao et al.   NATURE IMMUNOLOGY

Dexamethasone enhances necrosis-like neuronal death in ischemic rat hippocampus involving μ-calpain activation

(2014) Georg Johannes Müller et al.   EXPERIMENTAL NEUROLOGY

Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death

(2014) C-S Yang et al.   ONCOGENE

Inferring tumour purity and stromal and immune cell admixture from expression data

(2013) Kosuke Yoshihara et al.   Nature Communications